Physician profile
George E Thomas
NPI 1144237942
$756.09
in general payments reported to CMS, 2019-2025
20 companies · $84.51 in 2025
The $84.51 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $292 · 2021: $49.43 · 2025: $84.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $111.47 | 2019 | |
| Novo Nordisk INC | $97.50 | 2020-2025 | Wegovy |
| Allergan, INC. | $58.05 | 2020 | |
| Ironwood Pharmaceuticals, INC | $57.96 | 2019-2020 | |
| Abbvie INC. | $49.43 | 2021 | |
| Daiichi Sankyo INC. | $46.12 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.11 | 2019 | |
| Amgen INC. | $39.92 | 2019 | |
| Mylan Specialty L.P. | $37.11 | 2020 | |
| Amarin Pharma, INC. | $36.47 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.61 | 2020 | |
| Novartis Pharmaceuticals Corporation | $26.13 | 2019-2020 | |
| Pfizer INC. | $24.19 | 2019 | |
| Glaxosmithkline, LLC. | $22.54 | 2019 | |
| Lilly USA, LLC | $13.83 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.42 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2020 | |
| Eisai INC. | $12.13 | 2020 | |
| Avanir Pharmaceuticals, INC. | $11.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.